Lentiviral transduction of human T-lymphocytes with a RANTES intrakine inhibits human immunodeficiency virus type 1 infection

Intrakines, modified intracellular chemokines, offer a novel strategy to prevent cellular entry of HIV-1 by blocking the surface expression of HIV-1 co-receptors. To investigate potential clinical applications of the RANTES-intrakine, we explored the use of HIV-1-based lentiviral vectors for therape...

Full description

Saved in:
Bibliographic Details
Published inGene therapy Vol. 9; no. 13; pp. 889 - 897
Main Authors SCHROERS, R, DAVIS, C. M, WAGNER, H-J, CHEN, S-Y
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.07.2002
Subjects
Online AccessGet full text

Cover

Loading…